Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ivor Lewis esophagogastrectomy.

Francis C Nichols1, Mark S Allen, Claude Deschamps

  • 1Division of General Thoracic Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

The Surgical Clinics of North America
|June 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Society of Thoracic Surgeons 2024 Member Practice Survey.

The Annals of thoracic surgery·2025
Same author

Long-Term Survival and CANARY-Based Artificial Intelligence for Multifocal Lung Adenocarcinoma.

Mayo Clinic proceedings. Digital health·2025
Same author

Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy.

Chest·2023
Same author

Esophagectomy Enhanced Recovery After Surgery Initiative Results in Improved Outcomes.

The Annals of thoracic surgery·2023
Same author

Determinants of Long-term Survival Decades After Esophagectomy for Esophageal Cancer.

The Annals of thoracic surgery·2023
Same author

Impact of FDG PET Standardized Uptake Value in Resected Clinical Stage IA Non-Small Cell Lung Cancer.

The Annals of thoracic surgery·2023
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Ivor Lewis esophagogastrectomy is a safe surgical option for esophageal cancer, enabling lymph node resection. However, survival rates are low in advanced stages, necessitating further research into multimodality therapies.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Esophageal cancer presents a significant oncological challenge.
  • Surgical resection is a primary treatment modality.
  • Optimizing surgical techniques and assessing outcomes are crucial.

Purpose of the Study:

  • To evaluate the safety and efficacy of the Ivor Lewis esophagogastrectomy for esophageal cancer.
  • To analyze survival outcomes based on cancer stage.
  • To identify areas for improvement in treatment strategies.

Main Methods:

  • Retrospective analysis of patients undergoing Ivor Lewis esophagogastrectomy.
  • Assessment of surgical technique, including lymph node dissection.
  • Correlation of survival data with clinicopathological factors, particularly cancer stage.

Related Experiment Videos

Main Results:

  • Ivor Lewis esophagogastrectomy demonstrated a safe surgical profile.
  • The technique facilitates resection of critical lymph node stations.
  • Survival is strongly dependent on the stage of esophageal cancer, with lower rates in advanced disease.
  • Systemic recurrence remains a significant concern in advanced stages.

Conclusions:

  • Ivor Lewis esophagogastrectomy is a viable surgical approach for esophageal cancer.
  • Further investigation into multimodality treatment is essential to improve outcomes, especially for advanced stages.
  • This study provides a baseline for evaluating novel therapeutic options.